Zoetis has announced that Bovi-shield Gold FP® 5 and Bovi-Shield Gold FP 5 HB products, which help producers further protect their cow herds against infectious bovine rhinotracheitis (IBR) and bovine viral diarrhea (BVD), have recently earned an additional label claim from the U.S. Department of Agriculture against fetal infection caused by (BVD) Types 1 and 2 viruses.

“With the value of calves in today’s market, helping protect every pregnancy has become even more important for cattle producers. The additional label claim against BVD fetal infection assures producers that our Bovi-Shield product can help protect the pregnancy through the critical stages of gestation, which is a benefit for cattle producers,” said Nathan Voris, DVM, MBA, Senior Marketing Manager, Cattle Vaccines with Zoetis. “Continued innovations in Zoetis reproductive vaccines help keep the cow herd healthier. Healthy pregnancies lead to healthy calves and ultimately, an improved bottom line for producers.”

Unprotected cows exposed to BVD Types 1 and 2 viruses may experience pregnancy loss or the delivery of weak or BVD persistently infected (PI) calves. The Bovi-Shield Gold product lines have the highest level of fetal protection of any reproductive vaccine available to cow/calf producers.

“This level of fetal protection helps maximize the reproductive potential of your cows, helping to ensure a healthy productive calf every year,” Dr. Voris added. “I recommend producers work with their veterinarian to identify the right vaccine for the challenges on their operation. Selecting vaccines with the strongest label claims can help protect the herd from diseases that can harm the bottom line.”

Zoetis also offers a Fetal Protection Guarantee when Bovi-Shield vaccines are used in herds according to label directions. The agreement guarantees that 100% of calves are born free from BVD persistent infection, and that the herd is protected against IBR abortion.

More information on this line of vaccines is available online